Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Cerebral Thromboembolism After TAVR
2016-001777-33Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban in aortic stenosis (AS) and cerebral sinovenous thrombosis (CSVT) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Jun 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
aortic stenosis (AS)cerebral sinovenous thrombosis (CSVT)
Beyond the preview
Go deeper on 2016-001777-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001777-33.